The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Patents, Royalties, Other Intellectual Property - Saniona A/S
Screening of 129 FDA approved anti-cancer drugs in colorectal cancer cell lines resistant to oxaliplatin or irinotecan (SN38).
 
Jan Stenvang
No Relationships to Disclose
 
Christine Hjorth Andreassen
No Relationships to Disclose
 
Nils Brünner
Employment - Medical Prognosis Institute; Oncology Venture; WntResearch
Leadership - Medical Prognosis Institute; Oncology Venture; WntResearch
Stock and Other Ownership Interests - Medical Prognosis Institute; Oncology Venture; WntResearch
Honoraria - Medical Prognosis Institute; Oncology Venture; WntResearch
Consulting or Advisory Role - Medical Prognosis Institute; Oncology Venture; WntResearch
Research Funding - Medical Prognosis Institute (Inst); Oncology Venture (Inst); WntResearch (Inst)
Patents, Royalties, Other Intellectual Property - Saniona A/S
Travel, Accommodations, Expenses - Medical Prognosis Institute; Oncology Venture; WntResearch